INNT
TOTAL INVALIDATION PROCESSED BY THE IB
08/24/2024
Back to search
Official data from USPTO
PG PHARGENTIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
08/24/2024
Trademark type
Combined
Nice classes
1, 5
Filing date
04/06/2016
Registration date
05/16/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/01/2023
Last transaction
12/01/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CH
Examiner
MARTIN, CHRISTINE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized letters "PG" appearing in the colors blue and orange next to the word "PHARGENTIS" appearing in the color grey. The color white appears for background purposes only and is not claimed as a feature of the mark.
Holders and representatives
Holders
Phargentis S.A.
Representatives
Jan Tamulewicz Katten Muchin Rosenman LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical productschemical preparations for scientific usecultures of microorganisms other than for medical and veterinary usenucleotide matrices and proteins for scientific and medical research
Class 5
Pharmaceutical preparations for the treatment of disorders of the nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; pharmaceutical preparations for the treatment of disorders of inflammatory origin; pharmaceutical preparations used in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology as well as for treatment of gastroenterological disorders; pharmaceutical preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularsexual dysfunctiongenitourinarycardiopulmonaryoncologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system diseases and disorders; cultures of microorganisms for pharmaceuticalmedical and veterinary use
Publications
History of USPTO decisions and trademark events.
33 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/08/2024
INPC
INVALIDATION PROCESSED
08/08/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/02/2024
C71T
CANCELLED SECTION 71
12/01/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/16/2022
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
10/06/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/23/2017
FIMP
FINAL DISPOSITION PROCESSED
08/22/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/16/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2017
PUBO
PUBLISHED FOR OPPOSITION
02/28/2017
GPNX
NOTIFICATION PROCESSED BY IB
02/24/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/08/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/08/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/25/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
01/25/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/25/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
01/25/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/25/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/24/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/24/2017
RFNT
REFUSAL PROCESSED BY IB
08/12/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/27/2016
RFRR
REFUSAL PROCESSED BY MPU
07/27/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/27/2016
CNRT
NON-FINAL ACTION WRITTEN
07/26/2016
DOCK
ASSIGNED TO EXAMINER
07/21/2016
MAFR
APPLICATION FILING RECEIPT MAILED
07/19/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/14/2016
Continuous trademark protection
Get notified about every new filing that threatens PG PHARGENTIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.